Ivermectin Stada

Ivermectin, the active ingredient in Ivermectin Stada, is a macrocyclic lactone anthelmintic presented as an oral tablet for oral use. It treats parasitic infections such as onchocerciasis, strongyloidiasis, scabies, lymphatic filariasis and other intestinal helminth infections.

GNH USA supplies Ivermectin Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Ivermectin is an antiparasitic agent used to treat a range of helminth and ectoparasite infections. - Onchocerciasis: reduces microfilarial load and helps prevent disease progression. - Strongyloidiasis: eliminates intestinal larvae and prevents systemic dissemination. - Scabies: eradicates Sarcoptes scabiei mites, relieving skin lesions. - Lymphatic filariasis (in combination therapy): contributes to parasite clearance and transmission interruption. - Other intestinal helminth infections: broad‑spectrum activity against various nematodes.

Ivermectin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Dizziness: transient feeling of light‑headedness. - Nausea: mild to moderate upset stomach. - Diarrhea: loose stools during treatment. - Abdominal pain: cramping or discomfort. - Pruritus: itching at the site of infection. - Headache: mild to moderate tension.

Serious or Rare Side Effects: - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatotoxicity: elevated liver enzymes or hepatitis. - Neurologic effects: seizures, ataxia, or altered consciousness. - Anaphylaxis: acute allergic response requiring emergency care. - Vision changes: blurred vision or optic neuritis. - Cardiac arrhythmias: rare conduction disturbances.

Before prescribing Ivermectin Stada, consider the following precautions. - Assess liver function: evaluate hepatic status as metabolism is hepatic. - Review concomitant medications: avoid drugs that may increase ivermectin exposure. - Monitor for neurologic symptoms: especially in patients with blood‑brain barrier disorders. - Use with caution in the elderly: increased susceptibility to adverse effects. - Pregnancy and lactation: safety not established; weigh benefits against risks. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Ivermectin may interact with several medicines; awareness helps prevent adverse outcomes.

Major Interactions (Avoid): - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk. - Carbamazepine: induces metabolism, reducing ivermectin plasma levels. - Erythromycin: can raise ivermectin concentrations, heightening toxicity.

Moderate Interactions (Monitor Closely): - Ketoconazole and other azole antifungals: may increase ivermectin exposure. - Phenytoin: may lower ivermectin levels, reducing efficacy. - P‑glycoprotein inhibitors (e.g., verapamil): can raise systemic concentrations. - Antiretroviral agents (e.g., ritonavir): may alter ivermectin metabolism. - St. John’s wort: may decrease ivermectin exposure through enzyme induction.